NDC 71335-1381

acyclovir

Acyclovir

acyclovir is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Acyclovir.

Product ID71335-1381_aa39326b-7a0d-487d-b170-a0b77f2fa6a2
NDC71335-1381
Product TypeHuman Prescription Drug
Proprietary Nameacyclovir
Generic NameAcyclovir
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2006-03-13
Marketing CategoryANDA / ANDA
Application NumberANDA077309
Labeler NameBryant Ranch Prepack
Substance NameACYCLOVIR
Active Ingredient Strength800 mg/1
Pharm ClassesDNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 71335-1381-0

500 TABLET in 1 BOTTLE (71335-1381-0)
Marketing Start Date2008-10-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-1381-3 [71335138103]

acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA077309
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-10-28

NDC 71335-1381-7 [71335138107]

acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA077309
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-10-28

NDC 71335-1381-9 [71335138109]

acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA077309
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-10-28

NDC 71335-1381-4 [71335138104]

acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA077309
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-10-28

NDC 71335-1381-6 [71335138106]

acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA077309
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-10-28

NDC 71335-1381-2 [71335138102]

acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA077309
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-10-28

NDC 71335-1381-0 [71335138100]

acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA077309
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-10-28

NDC 71335-1381-1 [71335138101]

acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA077309
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-10-28

NDC 71335-1381-8 [71335138108]

acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA077309
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-10-28

NDC 71335-1381-5 [71335138105]

acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA077309
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-10-28

Drug Details

Active Ingredients

IngredientStrength
ACYCLOVIR800 mg/1

Pharmacological Class

  • DNA Polymerase Inhibitors [MoA]
  • Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
  • Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
  • Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
  • Nucleoside Analog [EXT]

NDC Crossover Matching brand name "acyclovir" or generic name "Acyclovir"

NDCBrand NameGeneric Name
0093-3630Acycloviracyclovir
0093-8940AcyclovirAcyclovir
0093-8943AcyclovirAcyclovir
0093-8947AcyclovirAcyclovir
0143-9657AcyclovirAcyclovir
0143-9658AcyclovirAcyclovir
0168-0825acycloviracyclovir
0378-8700Acycloviracyclovir
0378-8712AcyclovirAcyclovir
0440-6030AcyclovirAcyclovir
0440-7033acycloviracyclovir
0472-0082AcyclovirAcyclovir
0591-1159Acycloviracyclovir
0713-0630AcyclovirAcyclovir
0904-5789ACYCLOVIRACYCLOVIR
0904-5790acycloviracyclovir
10544-039Acycloviracyclovir
10544-089Acycloviracyclovir
10544-101AcyclovirAcyclovir
68071-1841AcyclovirAcyclovir
68071-3155AcyclovirAcyclovir
68071-3222AcyclovirAcyclovir
68071-4528AcyclovirAcyclovir
68071-4559acycloviracyclovir
68071-4345AcyclovirAcyclovir
68084-109AcyclovirAcyclovir
68084-108AcyclovirAcyclovir
68071-4790AcyclovirAcyclovir
68071-4799AcyclovirAcyclovir
68084-107ACYCLOVIRACYCLOVIR
68382-125acycloviracyclovir
68382-049acycloviracyclovir
68382-048acycloviracyclovir
68382-668acycloviracyclovir
68382-126acycloviracyclovir
68382-792acycloviracyclovir
68382-791acycloviracyclovir
68382-992acycloviracyclovir
68462-746acycloviracyclovir
68788-6360acycloviracyclovir
68788-0505AcyclovirAcyclovir
68788-0504AcyclovirAcyclovir
68788-0715AcyclovirAcyclovir
68788-8989acycloviracyclovir
68788-6827ACYCLOVIRACYCLOVIR
68788-7382acycloviracyclovir
68788-7378acycloviracyclovir
68788-9783AcyclovirAcyclovir
68788-7342AcyclovirAcyclovir
68788-9690AcyclovirAcyclovir

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.